ABSTRACT
This study examined the effects of a heating system using a ground source geothermal heat pump (GHP). A GHP was installed in a pig house, and a comparative analysis was performed between the GHP and the control (conventional heating system) in terms of the production performance, housing environment, noxious gas emissions, electricity consumption, and economics. The geothermal system performance index, such as the coefficient of performance (COP), inlet, and outlet temperature, were also evaluated. The outflow temperature during each period (weaning, growing, and finishing) was significantly higher than the inflow temperature in all three components of the GHP system. Similarly, the average internal temperature of the GHP-connected pig house was increased (p < 0.05) during each period. The carbon dioxide (CO2) concentration, electricity usage, and cost of electricity during the 16-week experimental period were reduced significantly in the GHP system relative to the control. The concentrations of ammonia (NH3) during the growing and finishing period and the concentrations of formaldehyde during the weaning phase were also lower in the GHP-installed pig house (p < 0.05). These results indicate that the GHP system can be used as an environmentally friendly renewable energy source in pig houses for sustainable pig production without harming the growth performance.
ABSTRACT
Zinc deficiency in patients with atopic dermatitis (AD) and the use of zinc supplementation is still controversial. We measured hair zinc levels in 58 children with AD and 43 controls (age range 2-14 years). We also investigated the efficacy of oral zinc supplementation in AD patients with low hair zinc levels by comparing eczema assessment severity index (EASI), transepidermal water loss (TEWL), and visual analogue scales for pruritus and sleep disturbance in patients receiving zinc supplementation (Group A) and others not receiving supplementation (Group B). At baseline, the mean zinc level was significantly reduced in AD patients (113.1 µg/g vs. 130.9 µg/g, p = 0.012). After 8 weeks of supplement, hair zinc level increased significantly in Group A (p < 0.001), and EASI scores, TEWL, and visual analogue scales for pruritus improved more in Group A than in Group B (p = 0.044, 0.015 and < 0.001, respectively). Thus, oral zinc supplementation may be effective in AD patients with low hair zinc levels.
Subject(s)
Dermatitis, Atopic/drug therapy , Hair/chemistry , Trace Elements/administration & dosage , Zinc/administration & dosage , Zinc/analysis , Administration, Oral , Adolescent , Child , Child, Preschool , Dermatitis, Atopic/complications , Female , Humans , Male , Pruritus/etiology , Pruritus/therapy , Severity of Illness Index , Sleep Initiation and Maintenance Disorders/etiology , Sleep Initiation and Maintenance Disorders/therapy , Visual Analog Scale , Water Loss, Insensible , Zinc/deficiencyABSTRACT
Extramammary Paget disease (EMPD) is a rare skin condition usually found in the anogenital region. Histologically, EMPD may be associated with varying degrees of epidermal hyperplasia classified as squamous, papillomatous, or fibroepitheliomatous. We report a case of EMPD in a 90-year-old man who presented with well-demarcated plaques and a nodule in the pubic area with fibroepitheliomatous hyperplasia.
Subject(s)
Paget Disease, Extramammary , Perineum/pathology , Skin/pathology , Aged, 80 and over , Asymptomatic Diseases , Diagnosis, Differential , Humans , Hyperplasia/diagnosis , Hyperplasia/pathology , Hyperplasia/physiopathology , Male , Paget Disease, Extramammary/diagnosis , Paget Disease, Extramammary/pathology , Paget Disease, Extramammary/physiopathologySubject(s)
Acanthoma/surgery , Lasers, Gas/therapeutic use , Skin Neoplasms/surgery , Acanthoma/pathology , Aged , Humans , Male , Mouth/pathology , Skin Neoplasms/pathologyABSTRACT
Dermatomyositis (DM) is an idiopathic inflammatory process characterized by proximal muscle weakness and cutaneous lesions, such as the Gottron's sign, heliotrope rash, and erythematous photosensitive rash. Administration of systemic agents for the treatment of underlying systemic diseases leads to remission of the cutaneous lesions in many cases. However, cutaneous lesions may remain refractory to treatment. Pimecrolimus is a calcineurin inhibitor with combined anti-inflammatory and immunomodulatory activity. It has high affinity to the skin and low permeation potential, even in patients with acute skin inflammation and in those undergoing post-topical corticosteroid therapy. We herein report two DM patients whose cutaneous lesions were refractory to conventional treatment but showed dramatic response to topical pimecrolimus. The clinical outcomes suggest that topical pimecrolimus may be a good therapeutic alternative for the management of the cutaneous lesions of DM.
